Review the side-effects of Aclidinium Bromide Oral Inhalation as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.
Most Common - Headache, common cold and cough.
Miscellaneous - Nose inflammation, diarrhea, sinus inflammation, toothache, vomiting.
Once opened, the inhaler should be discarded after 45 days.
Aclidinium use should be discontinued in patients who have severe bronchospasm after treatment with the drug.
Tudorza Pressair
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.
Most Common - Headache, common cold and cough.
Miscellaneous - Nose inflammation, diarrhea, sinus inflammation, toothache, vomiting.
Other Precautions :
Avoid excess dosage.Once opened, the inhaler should be discarded after 45 days.
Aclidinium use should be discontinued in patients who have severe bronchospasm after treatment with the drug.
Drug Name : Aclidinium Bromide Oral Inhalation
Aclidinium Bromide Oral Inhalation is used for the long-term maintenance treatment of bronchospasm or sudden constriction of the airways associated with chronic obstructive pulmonary disease (COPD), chronic bronchitis, and emphysema or damaged air sacs in the lungs.Trade Names for Aclidinium Bromide Oral Inhalation
International :
Tudorza Pressair
